Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience
São Paulo med. j
;
118(6): 173-8, Nov. 2000. graf, tab
Article
in English
| LILACS
| ID: lil-277625
ABSTRACT
CONTEXT Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) using conventional chemotherapy in about 55-85 percent. However, 30 percent of patients fail to achieve CR and the remission duration is often only about 12 months. More intensive treatment after CR seems to be necessary in order to maintain CR and obtain a definitive cure. In Brazil, few reports have been published on this important subject. OBJECTIVE:
The aim of this study was to describe a Brazilian experience in the treatment of "de novo" acute myeloid leukemia (AML) in younger adult patients (age < 60 years).DESIGN:
Retrospective analysis.SETTING:
University Hospital, Hematology and Hemotherapy Center, State University of Campinas, Brazil...
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Leukemia, Myeloid
Type of study:
Observational study
/
Prognostic study
/
Risk factors
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
São Paulo med. j
Journal subject:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
Medicine
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Year:
2000
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Estadual de Campinas/BR
Similar
MEDLINE
...
LILACS
LIS